Reversal Reaction to Hansen’s Disease
May 2005 | Volume 1 | Issue 1 | Original Article | 70 | Copyright © May 2005
Ming H. Jin, MD; Arash Kimyai-Asadi, MD and William R. Lewis. MD
AbstractA 25-year-old man with a history of mid-borderline (BB) Hansen's disease developing a reversal reaction after starting dapsone and rifampin therapy is presented. His clinical features included erythematous, edematous plaques and peripheral neuropathy. Reversal reactions are caused immunologically by enhanced cell-mediated (Th-1) immunity to Mycobacterium leprae, resulting in inflammation of infected tissues, such as skin and nerves. Acute neuritis can lead to permanent nerve damage and necessitate prompt treatment with prednisone and/or clofazamine.